Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.50 (2.857%)
Market Cap: £27.13m
PMP Live PriceLast checked at - London Stock Exchange

Intraday Portmeirion Share Chart

Acquisition of AromaWorks London

15 Aug 2022 07:00

RNS Number : 9270V
Portmeirion Group PLC
15 August 2022
 

15 August 2022

Portmeirion Group PLC (the 'Group')

Acquisition of AromaWorks London

 

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands is delighted to announce it has acquired the AromaWorks London brand, intellectual property and certain stock, trade and assets with no ongoing liabilities from AromaWorks Limited (company currently in Administration) ('AromaWorks'). 

AromaWorks manufactures a range of home fragrance products using essential oils in the health and wellbeing category with a retailer customer base in the UK and US.

The total consideration of £0.44 million for the intellectual property, inventory and certain fixed assets is payable in cash and has been financed from the Group's existing cash resources. For the year ended 31 December 2021 (unaudited), AromaWorks had sales of £4.1 million and a headline profit before taxation of £0.3 million.

This acquisition will add further scale to our existing home fragrance business, Wax Lyrical, and we expect to deliver on cost synergies and cross-selling opportunities within the first twelve months.

Mike Raybould CEO commented:

"We are delighted to bring AromaWorks London into our family of brands. It has established an impressive base of UK and US customers in the last few years and is highly synergistic with our existing home fragrance business, Wax Lyrical. We have invested significantly in the last 2 years in our UK manufacturing and testing facilities and this gives us a great opportunity to further leverage both our production capabilities and our global sales infrastructure as part of our strategy to grow our sales alongside improving the Group operating margins over the next 3 years. AromaWorks has successfully opened its first US market customer account listings in the past six months and we look forward to supporting and enabling growth in that key market through our existing US sales and distribution operation."

 

Notes: This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").

 

Enquiries:-

 

Portmeirion Group PLC:

 

 

Mike Raybould

+44 (0) 1782 743443

mraybould@portmeiriongroup.com

Chief Executive

David Sproston

 

+44 (0) 1782 743443

 

dsproston@portmeiriongroup.com

Group Finance Director

 

 

 

Hudson Sandler:

 

 

Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

Nick Moore

 

nmoore@hudsonsandler.com

 

 

Panmure Gordon

(Nominated Adviser and Broker):

 

+44 (0) 207 886 2500

Freddy Crossley

Corporate Finance

Rupert Dearden

Corporate Broking

 

Singer Capital Markets

(Joint Broker):

 

+44 (0) 207 496 3000

Peter Steel

Investment Banking

Rachel Hayes

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAKPAFDNAEFA
Date   Source Headline
30th Jun 20262:42 pmRNSReceipt of $2.7m from US Tariff refund claim
29th Jun 20269:51 amRNSNotification of major holdings
29th Jun 20269:48 amRNSNotification of major holdings
29th Jun 20269:18 amRNSNotification of major holdings
29th Jun 20267:00 amRNSCompletion of Asset Based Lending Facility
29th Jun 20267:00 amRNS-RSenior commercial hires
26th Jun 202612:30 pmRNSHolding(s) in Company
26th Jun 202611:17 amRNSHolding(s) in Company
25th Jun 20269:59 amRNSNotification of Major Holdings
24th Jun 20265:37 pmRNSHolding(s) in Company
23rd Jun 20264:32 pmRNSPDMR Shareholdings
23rd Jun 202611:36 amRNSResult of General Meeting and Total Voting Rights
10th Jun 20267:00 amRNSResult of Retail Offer
4th Jun 20268:00 amRNSProposed Retail Offer
4th Jun 20267:00 amRNSResult of Placing and Notice of General Meeting
3rd Jun 20264:40 pmRNSProposed Placing to raise at least £15 million
2nd Jun 20261:02 pmRNSAGM Resolutions
27th May 20263:08 pmRNSExercise of Options and Total Voting Rights
21st May 20263:30 pmRNS-RStatement re Government support for UK ceramics
11th May 202610:00 amRNSConfirmation of Director Appointment
6th May 20267:01 amRNSPreliminary Results
6th May 20267:00 amRNSDirectorate change
20th Apr 202612:10 pmRNSHolding(s) in Company
27th Feb 202610:37 amRNSHolding(s) in Company
12th Feb 20263:48 pmRNSNotification of Major Holdings
12th Feb 20263:38 pmRNSNotification of Major Holdings
3rd Feb 20267:00 amRNSFY 2025 Trading Update
8th Jan 20261:03 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RSenior strategic hires
6th Oct 20251:37 pmRNSInvestor Presentation via Investor Meet Company
25th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
21st Jul 20257:00 amRNSH1 2025 TRADING UPDATE
3rd Jun 20257:00 amRNSExercise of Options, PDMR & Voting Rights
20th May 20252:24 pmRNSAGM Resolutions
11th Apr 20257:00 amRNSAnnual Report & Accounts and Notice of AGM
7th Apr 20257:00 amRNSDirector's Dealing
2nd Apr 202512:04 pmRNSDirector's Dealing
2nd Apr 20257:20 amRNSDirector's Dealing
1st Apr 202511:39 amRNSDirector's Dealing
31st Mar 20257:00 amRNSPreliminary Results
17th Mar 20257:00 amRNSNotice of Results and Investor Presentation
6th Mar 20255:14 pmRNSHolding(s) in Company
20th Jan 20257:00 amRNSAppointment of Non-Executive Chairman
20th Dec 202410:02 amRNSHolding(s) in Company
17th Dec 20247:00 amRNSHolding(s) in Company
13th Dec 20247:00 amRNSTrading Update
28th Oct 20243:07 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSAppointment to the Board
19th Sep 20247:00 amRNSInterim Results
10th Sep 20247:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.